ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $301 | -13.3% | 55,264 | +6.8% | 0.00% | 0.0% |
Q2 2023 | $347 | -21.3% | 51,766 | +3.6% | 0.00% | 0.0% |
Q1 2023 | $441 | +5.0% | 49,966 | -9.2% | 0.00% | 0.0% |
Q4 2022 | $420 | -99.9% | 55,001 | +2.4% | 0.00% | 0.0% |
Q3 2022 | $382,000 | -9.9% | 53,701 | +2.3% | 0.00% | 0.0% |
Q2 2022 | $424,000 | -43.2% | 52,476 | -2.6% | 0.00% | -50.0% |
Q1 2022 | $747,000 | -43.5% | 53,866 | +14.2% | 0.00% | -33.3% |
Q4 2021 | $1,323,000 | -37.3% | 47,165 | -24.0% | 0.00% | -40.0% |
Q3 2021 | $2,109,000 | -20.4% | 62,066 | -4.2% | 0.01% | -28.6% |
Q2 2021 | $2,648,000 | +56.0% | 64,809 | +53.7% | 0.01% | +40.0% |
Q1 2021 | $1,697,000 | -32.3% | 42,156 | -0.5% | 0.01% | -37.5% |
Q4 2020 | $2,505,000 | +19.1% | 42,381 | -2.1% | 0.01% | +14.3% |
Q3 2020 | $2,104,000 | +3.2% | 43,275 | +2.6% | 0.01% | -12.5% |
Q2 2020 | $2,039,000 | +74.3% | 42,159 | +0.1% | 0.01% | +60.0% |
Q1 2020 | $1,170,000 | – | 42,123 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |